New Analysis Finds CRP Testing Followed by Rosuvastatin Therapy Cost-Effective

Researchers show that test and treat approach for C-reactive protein appears cost-effective; it also has the potential to be cost-saving.

Source: BWH News - February 7, 2011 Category: Hospital Management Source Type: news